Members of the nuclear steroid hormone superfamily mediate essential physiological functions. Steroid hormone receptors (SHR) act directly on DNA, regulate the synthesis of their target genes and are usually activated by ligand binding. Both endogenous and exogenous compounds and their metabolites may act as activators of SHR and disruptors of endocrine, cellular and lipid homeostasis. The endogenous ligands are generally steroids such as 17β-oestradiol, androgens, progesterone and pregnenolone. The exogenous compounds are usually delivered through the diet and include non-steroidal ligands. Examples of such ligands include isoflavanoids or phytooestrogens, and food contaminants such as exogenous oestrogens from hormone-treated cattle, pesticides, polychlorinated biphenyls and plasticisers. Certain drugs are also ligands; so nuclear receptors are also important drug targets for intervention in disease processes. The present review summarises recent reports on ligand-activated SHR that describe the selective regulation of a tightly-controlled cross-talking network involving exchange of ligands, and the control of major classes of cytochrome P450 (CYP) isoforms which metabolise many bioactive exogenous compounds. Many CYP have broad substrate activity and appear to be integrated into a coordinated metabolic pathway, such that whilst some receptors are ligand specific, other sensors may have a broader specificity and low ligand affinity to monitor aggregate levels of inducers. They can then trigger production of metabolising enzymes to defend against possible toxic nutrients and xenobiotic compounds. The influence of dietary intakes of nutrients and nonnutrients on the human oestrogen receptors (α and β), the aryl hydrocarbon receptor, the pregnane X receptor, the constitutive androstane receptor, and the peroxisome proliferator-activated receptors (α and γ), can be examined by utilising computer-generated molecular models of the ligand-receptor interaction, based on information generated from crystallographic data and sequence homology. In relation to experimental and observed data, molecular modelling can provide a scientifically sound perspective on the potential risk and benefits to human health from dietary exposure to hormone-mimicking chemicals, providing a useful tool in drug development and in a situation of considerable public concern.
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AhR, aryl hydrocarbon receptor; CAR, constitutive androstane receptor; CYP, cytochrome P450; DDT, dichlorodiphenyltrichloroethane; EDC, endocrine-disrupting chemicals; ER, oestrogen receptor; LBD, ligand binding domain; PCB, polychlorinated biphenyls; PPAR, peroxisome proliferatoractivated receptor; PXR, pregnane X receptor; SHR, steroid hormone receptor.
Endocrine-disrupting chemicals
Endocrine-disrupting chemicals (EDC) are substances that can cause adverse effects by interfering in some way with the body's hormonal or chemical messengers. Under the control of the central nervous system, hormones are secreted by the endocrine glands and exert control on other cells of the body. The endocrine system is complex, with many organs producing different hormones, contributing to a multifaceted feedback regulatory system that is deficient in the developing fetus and infant. EDC are differentiated from classical toxicants such as carcinogens, neurotoxicants and heavy metals, because they can interfere with normal blood hormone levels or the subsequent action of those hormones, but do not have a classical toxic effect. The effects can influence and disrupt the hormonal regulation and hormonal imprinting (in the fetus) of normal cell differentiation, growth, development, metabolism and reproduction throughout life. Endocrine disruption can occur at levels far lower than those of traditional concern to toxicologists. Sometimes high doses shut off effects that occur at low levels, and sometimes low and intermediate doses produce greater effects than those observed at high doses. Human populations are exposed to complex mixtures of 106 M. N. Jacobs and D. F. V. Lewis environmental and endogenous agents, which may act together or modulate one another to produce biological effects. While exogenous endocrine modulators can involve any hormonal system and be affected by normal physiological states (such as menstruation and menopause in women, the andropause in men, and puberty, the somatopause and adrenopause in both sexes), diet, stress and other lifestyle factors, the principal focus of the present review is on the effects of sex hormones, and especially oestrogenmediated effects, on the steroid hormone receptors (SHR) in human subjects where the ligands are delivered through the diet. The intention is that the present review will provide a basis for understanding some of the critical issues involved in hormone receptor-mediated toxicity, and the broad context involved.
Hormone dynamics
Accurate assessment of a chemical's potential to alter the endocrine system depends on consideration of the entire hormone dynamic pathway together with changes in hormone activity. Fig. 1 presents a simplistic model of hormone dynamics, following hormones from production to excretion. After a hormone is produced, circulating and intracellular binding proteins regulate the hormones bioavailability. Then the hormone triggers action by binding to a specific cellular receptor. The hormone is then either excreted in the urine after conjugation reactions in the liver, or biotransformed into another hormone, which will begin the cycle of bioavailability, action and excretion or biotransformation.
Hormones, and hormone-mimicking chemicals, can potentially affect each point in the hormone dynamic cycle, and each point in the steroid hormone pathway, and the enzyme families associated with the pathway. Assessing the mode of action of an EDC is further complicated by many feedback mechanisms within and between the different hormone systems, as well as interconnections with the nervous and immune systems. Current scientific knowledge of these systems is fragmentary, but the emerging picture suggests an interlinked fabric of hormone dynamics where the delicately balanced compensatory systems are easily perturbed. Hormone dynamics have evolved over a long period of time to deal with hormone and dietary phytochemical exposure, but they are not a rapid response system able to deal effectively with the synthetic chemicals of the twentieth and twenty-first centuries.
At the molecular level, receptors mediate alterations of hormone availability, action, excretion and biotransformation, in concert with the cytochrome P450 (CYP) enzyme system. Many receptors have been identified and are awaiting the recognition of specific ligands and functions, and it is likely that more receptors will be discovered in the future. Each type of receptor has the potential to regulate a distinct endocrine signalling pathway, of which we only have a rudimentary knowledge.
Hormone-mimicking chemicals and steroid hormone receptors
In recent years there have been many reports on the increasing incidence of breast cancer in women (Davis et al. 1993 (Davis et al. , 1997 Bradlow et al. 1995 Bradlow et al. , 1997 Davidson & Yager, 1997) and decreased sperm counts and increasing incidence of testicular cancer in men (Sharpe & Skakkebaek, 1993; Adami et al. 1994; Auger et al. 1995) , together with adverse wildlife effects that include birth defects, reproductive failures, and sexual abnormalities (Colburn et al. 1993 (Colburn et al. , 1999 Guillette & MacLachlan, 1996) . These conditions, related to oestrogen-like compounds, have stimulated research into both the chemical and molecular actions, and the clinical and epidemiological effects of a large variety of natural and synthetic oestrogens present in the environment (Falck et al. 1992; Hunter & Kelsey, 1993; Wolff et al. 1993; Krieger et al. 1994; Stevens et al. 1994; Ahlborg et al. 1995; Wolff & Toniolo, 1995; Gray et al. 1997; Hunter et al. 1997; Safe, 1997; Bernstein & Press, 1998 
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